1-(2-Nitrobenzylidenamino)-2,4-imidazolidinedione-[2,4,5-13C] structure
|
Common Name | 1-(2-Nitrobenzylidenamino)-2,4-imidazolidinedione-[2,4,5-13C] | ||
---|---|---|---|---|
CAS Number | 1007476-86-9 | Molecular Weight | 251.17 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C713C3H8N4O4 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of 1-(2-Nitrobenzylidenamino)-2,4-imidazolidinedione-[2,4,5-13C]2-NP-AHD-13C3 is the 13C labled 2-NP-AHD (HY-136457)[1]. 2-NP-AHD is a 2-nitrophenyl derivative of AHD (a metabolite of nitrofurans type of antibiotics), can be used as indicator of the illegal usage of nitrofuran agents[2]. |
Name | 1-[(E)-(2-Nitrobenzylidene)amino]-2,4-(13C3)imidazolidinedione |
---|---|
Synonym | More Synonyms |
Description | 2-NP-AHD-13C3 is the 13C labled 2-NP-AHD (HY-136457)[1]. 2-NP-AHD is a 2-nitrophenyl derivative of AHD (a metabolite of nitrofurans type of antibiotics), can be used as indicator of the illegal usage of nitrofuran agents[2]. |
---|---|
Related Catalog | |
In Vitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。 |
References |
Molecular Formula | C713C3H8N4O4 |
---|---|
Molecular Weight | 251.17 |
Exact Mass | 251.06500 |
PSA | 111.08000 |
LogP | 1.21750 |
RIDADR | NONH for all modes of transport |
---|
2-Np-Ahd-13C3 |